Floatz logo

59 assets in Neuroendocrine Neoplasm

Therapeutic assets addressing Neuroendocrine Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cabozantinib
Neuroendocrine Neoplasm
Fox Chase Cancer CenterP3BB (66)
Fluorouracilum
Neuroendocrine Neoplasm
ITM Solucin GmbHP3BB (66)
Irinotecan
Neuroendocrine Neoplasm
First Affiliated Hospital Xi'an Jiaotong UniversityP4BB (66)
Everolimus
Neuroendocrine Neoplasm
ExelixisP3BB (64)
Oxodotreotide
Neuroendocrine Neoplasm
Fundación de investigación HMP3BB (64)
Surufatinib
Neuroendocrine Neoplasm
Shanghai Changzheng HospitalP3BB (64)
Carboplatin
Neuroendocrine Neoplasm
First Affiliated Hospital Xi'an Jiaotong UniversityP4B (63)
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R*,R*))-
Neuroendocrine Neoplasm
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)P4B (63)
Cis-Diamminedichloroplatinum Ii
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P4B (62)
Oxaliplatin
Neuroendocrine Neoplasm
ITM Solucin GmbHP3B (62)
Capecitabine
Neuroendocrine Neoplasm
ITM Solucin GmbHP3B (60)
Etoposide
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2B (60)
L-Kappa-H-Gamma1 (Knob) Chain Anti-Dll3 (1-705) [L-Kappa Anti-Dll3 (1-214) [V-Kappa (Homo Sapiens Igkv1-17*03 (94.9%) -Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1-107) -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')] -38-Mer (Ggggse Gkssgsgses Kstegkssgs Gseskstggggs) Linker (215-252) -H-Gamma-1 Heavy Chain Anti-Dll3 (253-705) [Vh (Homo Sapiens Ighv1-46*01 (92.9%) -(Ighd) -Ighj6*01 (94.7%), Cdr-Imgt [8.8.17] (278-285.303-310.349-365)) (253-376)-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V32 Ch3 W22 (Knob) (Ch1 R120 (473) (377-474), Hinge 1-15 (475-489), Ch2 L1.3>A (493), L1.2>A (494) (490-599), Ch3 E12 (615), M14 (617), T22>W (625) (600-704), Chs K2>Del (705)) (377-705)]]; L-Lambda6-H-Gamma1 (Hole) Chain Anti-Cd3E (1-707) [L-Lambda6 Anti-Cd3 (1'-215') [V-Lambda Musmus/Homsap (Mus Musculus Iglv1*01 (82.3%) -Iglj1*01 (100%)/Homo Sapiens Iglv7-46*01 (76.8%) -Iglj3*02 (100%), Cdr-Imgt [9.3.9] (26'-34'.52'-54'.91'-99')) (1'-109') -Homo Sapiens Iglc6*01 (100%) (110'-215')] -38-Mer (Ggggse Gkssgsgses Kstegkssgsgseskstggggs) Linker (216'-253') -H-Gamma-1 Anti-Cd3E (254'-707') [Vh Musmus/Homsap (Mus Musculus Ighv10-1*02 (92.9%) -(Ighd) -Ighj3*01 (100%)/Homo Sapiens Ighv3-73*01 (87.0%) -(Ighd) -Ighj6*01 (81.8%) T123>L (373'), S128>A (378'), Cdr-Imgt [8.10.16] (279'-286'.304'-313'.352'-367')) (254'-378')-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V33 Ch3 S22, A24, V86 (Hole), G1V83 Ch3 R115, F116 (Ch1 R120 (475') (379'-476'), Hinge 1-15 (477'-491'), Ch2 L1.3>A (495'), L1.2>A (496') (492'-601'), Ch3 E12 (617'), M14 (619'), T22>S (627'), L24>A (629'), Y86>V (686'), H115>R (696'), Y116>F (697') (602'-706'), Chs K2>Del (707')) (379'-707')]]; Dimer (485-487':488-490')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Neuroendocrine Neoplasm
Boehringer IngelheimP2B (60)
Interferon Alfa-2B
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P3B (59)
Pembrolizumab
Neuroendocrine Neoplasm
University of Michigan Rogel Cancer CenterP2B (59)
Edotreotide
Neuroendocrine Neoplasm
British Columbia Cancer AgencyP3B (57)
Ipilimumab
Neuroendocrine Neoplasm
Olivia Newton-John Cancer Research InstituteP2B (57)
Zanzalintinib
Neuroendocrine Neoplasm
ExelixisP2/3B (57)
FDOPA
Neuroendocrine Neoplasm
University of AlbertaP3B (56)
Cyclophosphamide
Neuroendocrine Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (55)
Fludarabine
Neuroendocrine Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (55)
Fludeoxyglucose
Neuroendocrine Neoplasm
Anusha KalbasiP2CCC (55)
Furosemide
Neuroendocrine Neoplasm
University of AlbertaP3CCC (54)
Lanreotide
Neuroendocrine Neoplasm
RayzeBio, Inc.P3CCC (54)
Nivolumab
Neuroendocrine Neoplasm
Instituto do Cancer do Estado de São PauloP2CCC (54)
Sleeping Beauty Transposed Pbl
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Belinostat
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2CCC (52)
Entrectinib
Neuroendocrine Neoplasm
Hoffmann-La RocheP2CCC (51)
Foslinanib
Neuroendocrine Neoplasm
TaiRx, Inc.P2CCC (51)
Lenvatinib
Neuroendocrine Neoplasm
University of Michigan Rogel Cancer CenterP2CCC (51)
Nab-Sirolimus
Neuroendocrine Neoplasm
Aadi Bioscience, Inc.P2CCC (51)
Tcr Transduced T-Cells
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2CCC (51)
TIL
Neuroendocrine Neoplasm
Udai KammulaP2CCC (51)
mt-4561
Neuroendocrine Neoplasm
Tanabe Pharma America, Inc.P1/2CCC (48)
Olaparib
Neuroendocrine Neoplasm
Fundación de investigación HMP1/2CCC (48)
Tislelizumab
Neuroendocrine Neoplasm
Harbour BioMed (Guangzhou) Co. Ltd.P1/2CCC (48)
Pyruvate
Neuroendocrine Neoplasm
Rigshospitalet, DenmarkP2CC (47)
23me-00610
Neuroendocrine Neoplasm
23andMe, Inc.P1/2CC (43)
Atezolizumab
Neuroendocrine Neoplasm
University of FloridaP1/2CC (43)
Chm-2101 Car-T Cells
Neuroendocrine Neoplasm
Chimeric TherapeuticsP1/2CC (43)
Ezabenlimab
Neuroendocrine Neoplasm
Boehringer IngelheimP1CC (43)
Fapi-46
Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer CenterP1CC (43)
Tirapazamine
Neuroendocrine Neoplasm
Teclison Ltd.P1/2CC (43)
Tivozanib
Neuroendocrine Neoplasm
University of FloridaP1/2CC (43)
111in-abd147
Neuroendocrine Neoplasm
Thomas HopeEarly P1C (39)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes
Neuroendocrine Neoplasm
Anusha KalbasiP1C (39)
Bl-M14D1
Neuroendocrine Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (39)
Cid-078 Monotherapy
Neuroendocrine Neoplasm
Circle PharmaP1C (39)
Exemestane
Neuroendocrine Neoplasm
SAPU NANO (US) LLCP1C (39)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Neuroendocrine Neoplasm
Anusha KalbasiP1C (39)
Showing 1 to 50 of 59 assets
PreviousPage 1 of 2Next